Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome

National Institutes of Health (NIH)

Status: Completed

Conditions: Zollinger Ellison Syndrome

Study type: Observational

Funder types: NIH

Identifiers

NCT00001254

900137

90-DK-0137

Details and patient eligibility

About

This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.

Full description

This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

Enrollment: 273 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• INCLUSION CRITERIA:

New patients will be evaluated initially as described in the protocol entitled, "Diagnostic evaluation of patients with suspected abnormalities of gastric secretion" (89-DK-0005).

Only those patients that are being treated under the protocol entitled, "Medical Therapy of Zollinger-Ellison Syndrome" (protocol # 89-DK-0015) will be entered into this tumor localization and management protocol.

Trial design

273 participants in 1 patient group

Patients

Description:

Patients will Zollinger-Ellison Syndrome